Here is our round-up of five newsworthy stories for April 2018. Please click on the arrows on each side to navigate. Enjoy!
In conjunction with World Haemophilia Day on the 17th April, MIMS Today shared an informative article regarding the care of haemophilia carrier mothers.
Haemophilia is a hereditary blood disorder caused by a mutation in an X-chromosome gene that plays a role in blood clotting. Women with haemophilia are prone to bleeding complications throughout their pregnancy, and possibly also during and after childbirth.
More precautions should be taken by haemophilia B carriers than haemophilia A carriers, considering the increased risk of bleeding as clotting factors remain low throughout pregnancy.
Preventative treatment with anti-fibrinolytics and von-Willebrand factor is crucial, as is avoiding instrumental delivery whenever possible. Postpartum care should involve managing post-partum haemorrhage.
A study by scientists at Cardiff University demonstrates a new form of vaccination: solid tablets that do not require freezing or refrigeration for storage. Current vaccines need to be kept at low temperatures while in storage or in transit to prevent breakdown.
This particular vaccine was shown to protect against Influenza A. Further studies are needed to ensure long-term safety and efficacy before rolling it out to the public. Such a radical advance in vaccine design could help reach people in warzones and disaster-hit areas.
Engineering and IT conglomerate Hitachi is set to carry out studies to test for breast and colon cancers using urine samples. They believe this would aid early cancer detection and reduce treatment costs. Urine tests are also much less invasive than standard blood tests, a bane to individuals with needle phobia.
Prostate artery embolization, a new treatment for benign prostate enlargement, has been recommended for use by NICE. This follows official statements citing good evidence for its efficacy.
It is a non-invasive alternative to conventional treatments, which can cause impotence besides surgical side effects.
A UCL study found that NHS hospitals failed to diagnose dementia in more than a third of patients. Patients from ethnic minorities are more likely to be misdiagnosed compared to white patients.
The failure to identify dementia could be caused by a lack of public awareness of the typical signs of dementia. Red flags may go unnoticed by family members. It is also possible that clinicians chalk the signs and symptoms up to other diseases.